Skip to main content
Clinical Trials/NL-OMON49735
NL-OMON49735
Completed
N/A

An explorative intervention study to investigate the feasibility and safety of oral immunotherapy with different allergens in young children diagnosed with food allergy. - Oral immunotherapy in young children diagnosed with food allergy

Deventer Ziekenhuis0 sites240 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Food allergy
Sponsor
Deventer Ziekenhuis
Enrollment
240
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Children with an age of 9 to 24 months.
  • A proven food allergy (positive provocation and sensitization
  • demonstrated by a skin prick test\> 3mm and / or sIgE\> 0\.35kU / L) for chicken
  • egg, peanut, cow's milk, cashewnut, hazelnut, walnut and/or one of the more
  • rare allergens (as soja, pits and seeds (sesameseed and pine nut) and wheat).
  • Assessment of the presence of other food allergies (standard care) by
  • introduction in the diet and / or the determination of sensitization. From the
  • mentioned allergens, introduction into the diet or the diagnosis food allergy
  • has been made.
  • Written permission (signed informed consent form) from both parents /

Exclusion Criteria

  • Uncontrolled toddler asthma and / or frequent exacerbations (viral
  • wheezing) defined as toddlers who have been admitted to hospital \> 1x in the
  • past six months because of these complaints.
  • Uncontrolled eczema.
  • Severe gastrointestinal complaints such as gastroesophageal reflux
  • disease, where an underlying disease such as eosinophilic esophagitis (EoE)
  • cannot be excluded.
  • Active EoE.
  • Mastocytosis (also cutaneous).
  • Psycho\-social problems in the family that may be a barrier to a good

Outcomes

Primary Outcomes

Not specified

Similar Trials